Reports have shown that GDA competitively binds to the ATP-binding pocket in the NTD of GRP94 and inhibits its chaperone activity via downregulation of ATPase activity, resulting in the effective and potent killing of cancer cells [126]. The gene discussed is HSP90B1; the disease is cancer.